Equivalent Outcomes with Retransplantation and Primary Liver Transplantation in the Direct Acting Antiviral Era

Background The present multicenter study investigated whether equivalent outcomes to primary LT could be achieved with reLT and whether improvements in outcomes have taken place over time, particularly in the Direct Acting Antiviral (DAA) Era. Methods All reLT performed at Mayo Clinic-Florida, Mayo Clinic-Rochester and Mayo Clinic-Arizona were divided into Era 1 (2002-2007), Era 2 (2008-2012) and Era 3 (2013-2017) based on the date of reLT. Results Improvement in graft survival (GS) following reLT was seen over the 3 eras (p

https://ift.tt/2zqL8nl